OUTCOMES FOLLOWING SALVAGE AUTOLOGOUS STEM CELL TRANSPLANT (SCT) FOR MULTIPLE MYELOMA

被引:0
|
作者
Rondo, Silva C. [1 ]
Hassoun, H. [1 ]
Chimento, D. [1 ]
Jia, X. [1 ]
Giralt, S. [1 ]
Landau, H. J. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
134
引用
收藏
页码:S254 / S254
页数:1
相关论文
共 50 条
  • [41] Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma
    Schmidt, Walker M.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Dispenzieri, Angela
    Dingli, David
    Cook, Joselle
    Lacy, Martha Q.
    Kapoor, Prashant
    Leung, Nelson
    Muchtar, Eli
    Warsame, Rahma M.
    Kourelis, Taxiarchis
    Binder, Moritz
    Gonsalves, Wilson I.
    Gertz, Morie A.
    BLOOD, 2022, 140 : 7182 - 7184
  • [42] Toxicity and survival outcomes of autologous stem cell transplant in Multiple Myeloma patients with renal impairment
    Wang, Samuel
    Tan, Melinda
    Halim, Nurul Aidah Abdul
    Soekojo, Cinnie
    Chen, Yunxin
    Chng, Wee Joo
    Nagarajan, Chandramouli
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S139 - S139
  • [43] The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma
    Kiarash Salafian
    Christine Mazimba
    Leonid Volodin
    Indumathy Varadarajan
    Asal Pilehvari
    Wen You
    Ziyad O. Knio
    Karen Ballen
    Bone Marrow Transplantation, 2024, 59 : 459 - 465
  • [44] Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant
    Pasvolsky, Oren
    Saliba, Rima M.
    Masood, Adeel
    Mohamedi, Ali H.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Ramdial, Jeremy
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (04) : E37 - E41
  • [45] Impact of Obesity on Outcomes of Multiple Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplant
    Marcoux, Curtis
    Pasyar, Sarah
    Milton, Denai
    Khan, Hina
    Tanner, Mark
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Neupane, Niraj
    Lee, Hans
    Patel, Krina
    Tang, Guilin
    Lee, Jaehyun
    Aljawai, Yosra
    Kebriaei, Partow
    Thomas, Sheeba
    Orlowski, Robert
    Shpall, Elizabeth
    Champlin, Richard
    Qazilbash, Muzaffar
    Pasvolsky, Oren
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S236 - S236
  • [46] Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma
    Christopher Lemieux
    Lori S. Muffly
    David J. Iberri
    Juliana K. Craig
    Laura J. Johnston
    Robert Lowsky
    Parveen Shiraz
    Andrew R. Rezvani
    Matthew J. Frank
    Wen-Kai Weng
    Everett Meyer
    Judith A. Shizuru
    Sally Arai
    Michaela Liedtke
    Robert S. Negrin
    David B. Miklos
    Surbhi Sidana
    Bone Marrow Transplantation, 2021, 56 : 2664 - 2671
  • [47] Characteristics, Time Trend and Outcomes of Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Ailawadhi, Sikander
    Patel, Raj
    Meghji, Zahara
    Cochuyt, Jordan
    Hodge, David
    Vivek, Roy
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S138 - S139
  • [48] Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma
    Lemieux, Christopher
    Muffly, Lori S.
    Iberri, David J.
    Craig, Juliana K.
    Johnston, Laura J.
    Lowsky, Robert
    Shiraz, Parveen
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett
    Shizuru, Judith A.
    Arai, Sally
    Liedtke, Michaela
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2664 - 2671
  • [49] AUTOLOGOUS STEM CELL TRANSPLANT (SCT) IN PATIENTS WITH MULTIPLE MYELOMA (MM) OVER THE AGE OF 65 YEARS IS FEASIBLE AND SAFE
    Jagdeesh, D.
    Nath, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S254 - S254
  • [50] Second Autologous Stem Cell Transplant As Salvage Therapy in Multiple Myeloma - the Oregon Health and Science University Experience
    Galligan, Derek
    Williamson, Staci
    Myers, Jessie
    Silbermann, Rebecca W.
    Medvedova, Eva
    Schachter, Levanto
    Nagle, Sarah J.
    Chen, Andy
    Maziarz, Richard T.
    BLOOD, 2020, 136